Evidence Corner
Welcome to Evidence Corner. Here we try to explain the data behind the clinical decisions we make through deep-diving studies that have shaped how we treat patients with liver disease. For each clinical question, we’ve chosen a single study and with our digestible slides, we try to concisely highlight the key aspects of the study.
Evidence CornerWhy is it important to perform a diagnostic paracentesis on all patients with cirrhosis that are hospitalized?
Have you ever wondered why we always recommend performing a diagnostic paracentesis on patients with cirrhosis when they are hospitalized? This is the study for…
Nabeel WahidEvidence CornerIs baclofen a good option for maintaining alcohol abstinence in patients with cirrhosis and alcohol use disorder?
Treatment of alcohol use disorder in patients with cirrhosis is essential. Here is one RCT assessing whether baclofen is a safe and effective option! https://bit.ly/3HXb9Ll
Alex VogelEvidence CornerIs Lanifibranor a safe and effective therapy for NASH?
To read the full article: https://tinyurl.com/cnkzsjmn
Erin ClevelandEvidence CornerDoes Transient Elastography work to assess fibrosis in kids with NAFLD?
NAFLD is a widespread etiology for liver disease in the pediatric population; however the gold standard for diagnosis, a liver biopsy, is an invasive procedure.…
Kayla HartjesEvidence CornerDoes early OLT in patients with severe alcohol-related hepatitis improve survival?
Check out the first major trial of early LT in patients with AH
Erin ClevelandEvidence CornerDo albumin infusions improve outcomes in hospitalized patients with cirrhosis?
Does targeting a higher albumin level via IV albumin infusions improve outcomes in hospitalized patients with cirrhosis? The ATTIRE study attempted to investigate just that. …
Erin ClevelandEvidence CornerIs terlipressin and albumin effective for HRS type-1?
Treatment options for HRS type-1 are limited and prior data for terlipressin was mixed. This RCT tried to shed further light on the efficacy of…
Lizzie AbyEvidence CornerShould patients with alcohol-associated hepatitis be treated with NAC in addition to prednisolone?
Some people treat alcohol-associated hepatitis with both NAC and prednisolone and some with just prednisolone- here is the trial that underlies this decision: https://www.nejm.org/doi/full/10.1056/nejmoa1101214
Alex VogelEvidence CornerIs liver transplantation a viable treatment for intrahepatic cholangiocarcinoma?
Can liver transplantation be an effective therapy for intrahepatic cholangiocarcinoma?
Jennifer WangEvidence CornerShould patients with clinically significant portal hypertension be on beta-blockers?
Can beta-blockade in patients with clinically significant portal hypertension prevent decompensations? The PREDESCI trial sought out to determine just that!
Lizzie AbyIdeas?
Do you have suggestions for topics within this series? Are you a fellow interested in contributing? Please feel free to reach out via Twitter to the fellow lead or to Liver Fellow Network directly. You can also e-mail us at liverfellownetwork@gmail.com.